å»è¬åå ¬è¡šãããæŽå¯
é¿åŠè¬ãšããã€ã¹ - èªç¥çã§ã¯ãªããéžæã°ãããããã£ãŒç ç©¶æãå ¬è¡šããçµ±èšã«ãããšã2014幎ã«ç±³åœã§61äžäººã®å¥³æ§ãæ»äº¡ãã幎霢ã°ã«ãŒã(15-44幎)ã§æ»äº¡ããŸããã ãããã®å¥³æ§ã®çŽ10%ã¯ãä»»æã®é¿åŠæ¹æ³ã䜿çšããŸããã åœé£ã¯ãåç±³å°åã§ã®é¿åŠè¬ãå¿ èŠãšããªã(2015)ãæšå®ãã7%ã§ããã ãããã£ãŠãé¿åŠè¬ã¡ãŒã«ãŒã察åŠã§ããç±³åœã«ã¯æªå¯Ÿå¿ã®åžå ŽããããŸãã ãŸããç±³åœé¿åŠè¬ãããã€ã¹åžå Žåãã®è²»çšå¯Ÿå¹æã®é«ãä¿éºããªã·ãŒãå¶éãããŠããŸããçµ±èšã¯ã2015幎ã«åœé£ã«ãã£ãŠæããã«ãããæ®ºèã¯åã¢ã¡ãªã«ãªã©ã®å°åã§åªå¢ãªé¿åŠæ¹æ³ã§ãããšããèšåã åå®®å è£ çœ®(IUD)ãè ãª... ãã£ãšèŠã
ã«ã³ããã¹ãåæ³åããŠãªããªã€ãã¢ãŽãã¹ãè¬åžå Žæé·ã«åœ±é¿ãäžããŸããªããªã€ãã¯äžè¬ã«çã¿ã®æ²»çã®ããã«åŠæ¹ãããŸãã ãªããªã€ãè¬ã¯ã©ã¹ã«ã¯ãã¢ã«ãã¡ã€ã³ããã€ããã³ãã³ããªãã·ã³ãã³ãããã€ã³ãã³ãŒãã€ã³ãã¢ã«ãã¡ã€ã³ããã§ã³ã¿ãã«ãã¡ããã³ãå«ãŸããŠããŸãã 峿å¶å€ãäžç¢ã®æ²»çã«ã䜿çšãããŸãã ãªããªã€ãã¯ãé å€ãæ¶²äœãéèå ãçµç®ãããããŸãã¯ããŒãŒã³ãžãä»ããŠæäžããããšãã§ããŸãã åç±³ãšæ¬§å·ã®å é²åœã¯ããã®è¬ã®ä¹±çšã®é«ã¬ãã«ã®ããã«æåã§ãã ã³ãŒãã€ã³ãã¢ã«ãã£ãããã§ã³ã¿ãã«ããã€ããã³ãã³ãªã©ã®è¬ã¯ããããã®å°åã®è¬ã®å®¹æãªå¯çšæ§ã®ããã«ãç¹ã«ãããã®å°åã®äººå£ã®éã§ã... ãã£ãšèŠã
OsteosarcomaãŸãã¯éªšçã¯ãçã®çš®é¡ã¯ã骚çµç¹ã¯ç°åžžãªæé·ã瀺ããŠããŸãã åææ£éšããé éå°ã«åºãããªã¹ããªãµã«ãã¯è»¢ç§»æ§éªšç²è «ãšããŠç¥ãããŠããŸãã 転移æ§éªšç²è «ã¯ããã°ãã°èºã«åºãããŸããäžæ¹ãä»ã®éªšãè³ãŸãã¯ä»ã®èåšã«ããŸãäžè¬çã«åºãããŸãã 転移骚é«è «ã®çç¶ã¯ã骚ã®çã¿ã骚ã®éªšæãè «ããèµ€ã¿ã麻çºãããã³éãããé¢ç¯ã®åããªã©ãè «çã®äœçœ®ã«åºã¥ããŠå€åããŸãã è «çãèºã«è»¢ç§»ãããšãçç¶ã¯èžã®çã¿ãåŒåžã®äžè¶³ãè¡ãæ ¢æ§å³ãŸãã¯å鳎ã䌎ãã 転移æ§éªšç²è «ã®ããã®èšºæãã¹ãã¯CTã¹ãã£ã³ãMRIãXç·ãããã ã¹ãã£ã³ãçæ€ãããã³éªšã¹ãã£ã³ãå«ãã§ããŸãã 転移æ§éªšç²è «ã®æ²»... ãã£ãšèŠã
ç æ°ã®å¶åŸ¡ãšäºé²ã¯ã¯ãã³åžå Ž - æŽå¯ã¯ã¯ãã³ã¯ãç¹å®ã®çŸæ£ãŸãã¯çŸæ£ã®ã°ã«ãŒããå¶åŸ¡ãŸãã¯é²æ¢ããããã«åŸãããå ç«ã掻æ§åããããã«äœ¿çšãããçç©åŠçå£äœã§ãã 乳幌å ã ãã§ãªã倧人ã§ãå ç«åãçºæ®ããŸãã ããŸããŸãªçްèããã³ãŠã€ã«ã¹æ§çŸæ£ã«å¯Ÿããäºé²æ¥çš®ã¯ããã®äžéšã§ãã ææç äžçäžãã³ã³ãããŒã«ã ç æ°ã®äºé²ãšã³ã³ãããŒã«(ECDC)ãéç±çããã³äŸµè¥²æ§èºçŸæ£ã®50%以äžã®ã¯ã¯ãã³äºé²çŸæ£ããã³æ»äº¡ã®60%以äžã®ããã®ã¢ã«ãŠã³ãã«ãããšã 乳幌å ããæäººãŸã§ã®å®å šå ç«ã¹ã±ãžã¥ãŒã«ã¯ãã¯ã¯ãã³äºé²çŸæ£ã®è² æ ãå€§å¹ ã«åæžããŸãã äžçä¿å¥æ©é¢(WHO)ã«ãããšã2018幎ã®äºå®è¡šã«ã... ãã£ãšèŠã
ã¬ã³ã·ã§ããè² å·è æ²»ç ããŒã±ãã:ããã«ãã£ãŒã«ãã§ã®æåœå£«åŒŸåæ§ãã©ãŠããšãåŒã°ããã¬ã³ã·ã§ããã±ã¬ã¯ã匟䞞ããã€ãããŸãã¯éå©ãªãããã¡ã€ã©ãäœã«ã·ã§ããããããšãã«åŒãèµ·ããããç©ççãªãã©ãŠãã®åœ¢æ ã§ãã ã¬ã³ã·ã§ããã®æªæã¯ãéå°ãªåºè¡ãçµç¹ããã³èåšã®æå·ã麻çºãŸãã¯å£ãã骚ãªã©ã®å³ããæ¡ä»¶ãåŒãèµ·ããããŸãæ»äº¡ã«ã€ãªããå¯èœæ§ããããŸãã ã¬ã³ã·ã§ããã®åµå·ã®å³æå¹æã¯ãæªæã®å Žæã«äŸåãã貫éããã匟䞞ã®åãšé床ãå³ããåºè¡ã§ãã éæå·å®³æ²»ç補åã¯ãè² å·è ã®åœãæãããšã«ãã£ãŠæ°ç§ä»¥å ã«åºè¡ãæŽå©ããããšã«ãã£ãŠåœãæãããšãæåŸ ãããŸãããããã®è£œåã®äž»ãªç®çã¯ãè¡æ¶²ååº... ãã£ãšèŠã
ç Žå£çãªå°ããªäžžã现èè «ç(DSRCT)ã¯ãéåžžè ¹éšã§å§ãŸããèã«è»¢ç§»ãããŸããªçš®é¡ã®ç©æ¥µçãªè»çµç¹çãæããŸãã åœç«è¡çç ç©¶æã«ãããšãç æ°ã¯äž»ã«å¥³æ§ãããç·æ§ã«å€ãæ®åããŠããããã«ãåäŸãè¥ãæäººã«åœ±é¿ãäžããŸãã æ¬§å·é£åã®ä¿å¥ããã°ã©ã ã«ãããšããã¢ãã©ã¹ããã¯å°çްèè «çã¯æ¥µããŠãŸãã§ããã1989å¹Žã«æåã®èª¬æä»¥æ¥ãäžçäžã§æ°çŸä»¶ããå ±åãããŠããªãã ãŸããåœç«ããã€ã³ããªãžã§ã³ããããã¯ãŒã¯ãå ¬è¡è¡çã€ã³ã°ã©ã³ãã«ãããšãDSRCã®3ã€ã®çºççäŸã®ã¿ãã€ã®ãªã¹ã§2010幎ãã2013幎ã«ãããŠå ±åãããŸããã ç Žå£çãªå°ããªäžžã现èè «çã¯ãè ¹éšãšéªšç€ã®å åŽã®è ¹éšããã³éªšç€ã«èŠ... ãã£ãšèŠã
ç·ç¶çè «ã¯ãç·ç¶èœçްèãšåŒã°ããç¹ç¶åœ¢æçµåçµç¹ã®å¯äžã®è»çµç¹æªæ§è «çã®äžçš®ã§ãã ãããããã®ç¶æ ã¯ã©ã®å¹Žéœ¢ã§ãèµ·ããããããäžè¬çã«30ã60æ³ã®éã«èšºæãããã ã¬ãããlastomaãnevoid basal 现èã«ã«ãããŒãçå矀ãªã©ã®éºäŒçæ¡ä»¶ã«èŠããã§ããæ£è ã¯ãç·ç¶è «ãçºçããåŸåããããŸãã ããããç æ°ã®æ£ç¢ºãªåå ã¯äžæã§ãã ããã«ãæŸå°ç·çæ³ãåãããããªã³ãæµ®è «ãæã£ãŠããããäžé žåããã«ãŸãã¯ã¢ã«ã»ããã¯ãªã©ã®ååŠç©è³ªã«ãããããå人ã¯ãç·ç¶è «ãããåªããŠããã ãã®ç æ°ã¯çèçã«ãã£ãŠå¯Ÿç§°ãããæéãšãšãã«ææ°é¢æ°çã«å¢å ããŸãã ããã¯ãæŸå°ç·ã°ã©ãã®éªšã®ç å€ã«... ãã£ãšèŠã
ã°ããŒãã«ã¹ãã¬ããããŒã¯æ²»çåžå Žãè©äŸ¡ãããŸããUS$2,496.8 Mnãåãåãã 2021幎 ãããŠäŸ¡å€ã®äŸ¡å€ã«éããèŠéãã§ãUS$ 3,641.8 ã¡ãŒãã«ã«ãã£ãŠ2028幎ãåãåãã5.5%ã®CAGRéã®è·é¢2022幎ã2028幎ãåãåãã äžççãªã¹ãã¬ããããŒã¯æ²»çåžå Žã¯ãäžçäžã®è¥æºã®é«ãŸããšãã¹ãã¬ããããŒã¯ã«é¢ãããã¬ã¬ã³ã·ãŒã®å¢å ãšæžå¿µã«ããã匷ãæé·ãçµéšããŠããŸãã ãŸããå®å šã§å¹æçãªæ²»çã«å¯ŸããéèŠã®å¢å ããèªå® ã®å±ææ²»çã®åªå 床ãäžæãããšãåžå Žã®å¢å€§ãæåŸ ãããŸãã ããããªãããã¬ãŒã¶ãŒããã€ã¯ãããŒããã¬ãŒã·ã§ã³ã®é«ã³ã¹ãã人ã ã®æèã®æ¬ åŠãªã©ã®èŠ... ãã£ãšèŠã
ãã¿ãã³B6åžå Žã補åã¿ã€ãå¥ïŒå¡©é žããªããã·ã³ãããªãããµãŒã«-5-ãªã³é žå¡©ãããªãããµãã³ãªã©ïŒãäŸçµŠæºå¥ïŒåæããã³å€©ç¶ïŒã圢æ å¥ïŒç²æ«ãæ¶²äœãã«ãã»ã«ããã³é å€ïŒãçšéå¥ïŒå»è¬åãæ é€è£å©é£åãæ©èœæ§é£åããã³é£²æãåç©æ é€ãåç²§åããã³ããŒãœãã«ã±ã¢ïŒãæµéãã£ãã«å¥ïŒçŽæ¥ïŒ 販売ãå°å£²è¬å±ããªã³ã©ã€ã³ ãã£ãã«ãå°éåº)ãå°çå¥ (åç±³ãã©ãã³ã¢ã¡ãªã«ããšãŒããããã¢ãžã¢å€ªå¹³æŽãäžæ±ãã¢ããªã«)... ãã£ãšèŠã
ãã«ããããªã³ãè «ã¯ãç°åžžãªBãªã³ãçããçºçããæ¥æé·ãç¹åŸŽãšãããªã³ãç³»ã®çã§ãã Burkittãªã³ãè «ã¯éåžžãèŸèãèèãå«ããäœã®ããŸããŸãªéšåã§ãªã³ãç¯å¢æ®ãåŒãèµ·ãããŸãã 骚é«ãããã³äžæ¢ç¥çµç³»ã ãã«ããããªã³ãè «ã¯ãé«çŽéããžãã³ãªã³ãè «(NHL)ã®äžçš®ã§ãã äžçä¿å¥æ©é¢ã¯ã7ã7æ³ã®ã¢ããªã«ã®åäŸã«åœ±é¿ãåãŒãåå®®å èãšããŠããŒããããªã³ãè «ãåé¡ããã°ããŒãã«ã«èµ·ããèäœãHIV/AIDSã«èŠãã人ã ã«åœ±é¿ãäžããå ç«æ¬ ä¹åã¿ã€ããåé¡ããŸããã ããæ²»çã¢ããã€ã¶ãŒã«ãã調æ»ã«ãããšãããŒããããªã³ãè «ã¯å°å ãªã³ãè «ã®30%ãæäººã®ãªã³ãè «çäŸã®1%æªæºãç¹ã«å ç«ã·... ãã£ãšèŠã
ã¢ã¹ããã·ããã¯ãæåè³çްèããçºçããç ç¶ã§ãã çŸæ£ã¯ã现èã®ç¹æ®çã«åºã¥ããŠ4ã€ã®ç°ãªãã°ã«ãŒãã«åé¡ããããã®èœåã¯ãè¿ãã®çµç¹ã«åºããã ã°ã¬ãŒã Iãšã°ã¬ãŒãII astrocytomasã¯éæªæ§ã§ãããäœã°ã¬ãŒããšåŒã¶ããšãã§ããŸãã ããããã°ã¬ãŒãIIIãšã°ã¬ãŒãIVã¯æªæ§ããããããã«åºããèœåããããŸãã æéãçµã€ã«ã€ããŠãäœã°ã¬ãŒãã®ã¢ã¹ããã·ããã¯é«ã°ã¬ãŒãã®ã¢ã¹ããã·ããã«å€æŽããããšãã§ããŸãã ççŽIIIã®astrocytomasã¯ãŸãanaplasticastrocytomasãšããŠåŒã°ããŸãã Anaplastic Astrocytomaã¯ãŸããªå»åŠã®ç¶æ ... ãã£ãšèŠã
Botulinumã®æ¯çŽ ã¯èªç¶ã«çºçããClostridiumã®ãããªã³ã®çްèã«ãã£ãŠäœãåºããããããã¯ãã§ãã ãã®çްèã¯åããã³æµ·æŽã®æ²æ®¿ç©ã§èŠã€ããããæå®³ãªç¥çµããã·ã³ã®ãããªã³ã®æ¯çŽ ãäœãåºãããšãã§ããŸãã Botulinum toxinã¯ãç¹å®ã®ç¥çµäŒéç©è³ªã®æŸåºãé»å®³ããããããã¯å€ãã§ã, ç¹ã«ã¢ã»ãã«ã³ãªã³, ã¢ãŒã¿ãŒç¥çµã®çµç«¯ãã. ã¿ã€ãã®AããHã«ç€ºããããããªã³ã®æ¯çŽ ã®çŽ8ã®ã¿ã€ãããããŸãããããªã³ã®æ¯çŽ ã®ã¿ã€ãAããã³ãããªã³ã®æ¯çŽ ã®ã¿ã€ãBã¯ããŸããŸãªé¡ã®ç¶æ ã®åŠçœ®ã®ããã®åç²§åã®ããã·ãŒãžã£ã§äž»ã«ããã©ã³ãåBtoxã®äžã§åæ¥çã«è²©å£²ãããŸãã Botul... ãã£ãšèŠã
äžççãªç®èç§æ²»çåžå Žã¯ãUS$ 37,198.7 ã¡ãŒãã«2021幎ã¯äŸ¡å€ã®äŸ¡å€ã«éããèŠéãã§ãUS$ 63,917.4 ã¡ãŒãã«ã«ãã£ãŠ2028幎ãåãåãã8.0%ã®CAGRéã®è·é¢2022幎ã2028幎ãåãåãã äžççãªç®èç§æ²»çåžå Žã¯ãç®èç ã®è² æ ãäžæããäžçäžã®è(èå)人å£ã®å¢å ã«ãã匷ãæé·ãçµéšããŠããŸãã ãŸããå®å šã§å¹æçãªæ²»çè¬ã®éèŠã®å¢å ãšç®èç ã«é¢ãã人ã ã®éã§æèã®äžæãåžå Žã®æé·ãé«ããããšãæåŸ ãããŸãã ããããªãããç¹å®ã®ç®èç§è¬ã®æ·±å»ãªå¯äœçšãèšåºè©Šéšã®çµäºãªã©ã®èŠå ã¯ãäžççãªç®èç§æ²»çåžå Žã®æé·ã劚ããããšãæåŸ ãããŸããã°ããŒãã«ç®èç§ æ²»... ãã£ãšèŠã
ãããªã³ãããªãŠã åžå Žã補åã¿ã€ãå¥ïŒæªåç»ãããªã³ïŒUFHïŒããã³äœååéãããªã³ïŒLMWHïŒïŒãäŸçµŠæºå¥ïŒãã¿ç±æ¥ããã³ãŠã·ç±æ¥ïŒãæäžçµè·¯å¥ïŒéèå ããã³ç®äžïŒãçšéå¥ïŒéèè¡æ 塿 çïŒVTEïŒãå¿æ¿çްåããã³å åèçŸæ£ãè èéæãæè¡ããã³éçïŒ ã±ã¢ãªã©ïŒããšã³ããŠãŒã¶ãŒå¥ïŒç é¢ã倿¥æè¡ã»ã³ã¿ãŒïŒASCïŒãéæã»ã³ã¿ãŒãå°éã¯ãªããã¯ãªã©ïŒãæµéãã£ãã«å¥ïŒç é¢è¬å±ãå°å£²è¬å±ããªã³ã©ã€ã³è¬å±ïŒãå°çå¥ïŒåç±³ããšãŒããããã¢ãžã¢å€ªå¹³æŽãã©ãã³ã¢ã¡ãªã«ãäžæ±ãã¢ããªã«ïŒ... ãã£ãšèŠã
颚éªã®çã¿çæ³ã¯ãæ¥æ§è»çµç¹ã®æªæã®æ²»çã«äœ¿çšãããæŽåœ¢å€ç§ã®è¡åŸç¶æ ã®çã¿ã軜æžããããã«ãè¯æ§ããã³æªæ§ç å€ã®æ²»çãããã³çã¿ç®¡çã§äœ¿çšãããŸãã Cryotherapyã¯äžæ¹(ç®ã®è¡šé¢ã§)ãå€ç§çã«ãŸãã¯percutaneouslyå ããããšãã§ããŸãã ããã¯ãŸããèèãè èã骚ãbreastsããã³èºãç®èè «çãç®èã®ã¿ã°ãåçã®ç®èã¢ã¬ãããã³å·å®³ã®ããŸããŸãªç®èã®ç¶æ ãæ±ãã®ã«äœ¿çšããããšãã§ããŸããCryosurgeryããã·ãŒãžã£ã¯ç°åžžãªãã£ãã·ã¥ãç Žå£ããããã«æ¶²äœçªçŽ (ãã¢ã«ãŽã³ã®ã¬ã¹)ã®å©ãã«ãã£ãŠäœãåºãããæ¥µç«¯ãªé¢šéªã®äœ¿çšããå«ãã§ããŸãã åœç«ããç ç©¶æ(NCI)... ãã£ãšèŠã
çŽ°èæ§è£çè¬åžå Žãè¬å€ã¯ã©ã¹å¥ïŒãããã€ãããŸãŒã«ããªã³ã³ãµãããªã©ïŒãææçã®çš®é¡å¥ïŒååææãšåçºææïŒãæäžçµè·¯å¥ïŒçµå£ããã³å±æïŒãæµéãã£ãã«å¥ïŒç é¢è¬å±ãå°å£²è¬å±ããªã³ã©ã€ã³è¬å±ïŒãå°çå¥ïŒåç±³ããšãŒããããã¢ãžã¢å€ªå¹³æŽãã©ãã³ã¢ã¡ãªã«ãäžæ±ãã¢ããªã«ïŒ... ãã£ãšèŠã
å·ã¯ãç®èãçµç¹ãç©¿åºããç®èãå·ãåå£ãããã³ã¹ã¯ã©ããã«ãã£ãŠåŒãè£ãæªæã§ãã å·ã¯å€§æµå¶ç¶èµ·ãããŸããããŸããªå Žåã®çž«åãã¹ãããããŸãã¯æè¡ã§ã¯å·ãåŒãèµ·ãããŸãã å·æ²»çã¯ç®èã®æ²»çã§ã¯ãããŸããã æªæçŽåŸã«å§ãŸããŸãã å·ã¯æ¥æ§ã®å·ããã³æ ¢æ§ã®å·ã«åé¡ããããšãã§ããŸãã æ¿ããå·ã¯ãæ ¢æ§ã®åµå·ãæ°ã¶æããããå®å šã«æ²»çããã®ã«ãããæ°é±éããããŸãã æ ¢æ§ã®å·ã¯å§åçã¿ããã³éèã®è¶³æœ°çãå«ãã§ããŸãã 人éã®äœå ã®éåžžã®çç©åŠçããã»ã¹ãšããŠãåµå·æ²»çã¯ããmostasisãççã墿®ãæ¹é ãªã©ã®4ã€ã®æ£ç¢ºãã€é«åºŠã«ããã°ã©ã ããããã§ãŒãºã«ãã£ãŠéæãããŸãã éŠå°Ÿããç... ãã£ãšèŠã
æçç©è³ªã¯çްèã®å¢æ®ã现èã®äŒæã®å Žåã«ã¯çްèèªäœãããã®ããã«ãã³ã«ãã³ã¹ããã€ããã¢ã¬ã«ã®ãŒããã³ççç¶æ ãæ±ãã®ã«äœ¿çšãããŠããŸãã æçç©è³ªãå®è¡ã§ãããéã«ã³ã«ãã³ã¹ããã€ããå®è¡ã§ããæ©èœããããŸãã ææãå»åž«ã¯ãæçç©è³ªã埮çç©çްèå£ãæ»æããã®ãå©ããããã«ãã³ã«ãã³ã¹ããã€ãã«å ããŠæçç©è³ªã®çšéãåŠæ¹ããŸããççéçšãã³ã«ãã³ã¹ããã€ãã«ãã£ãŠåãçµãããšãã§ããŸãã ã³ã«ãã³ã¹ããã€ãã¯ãååŠåªäœãé»å®³ããããšã«ãã£ãŠççã«é¢é£ããçã¿ãæžå°ããŸãã äž¡æ¹ã®ååç©ã®æäžéã誀çšã¯ãå ç«ã·ã¹ãã é害ãªã©ã®å¯äœçšã«ã€ãªããå¯èœæ§ããããŸãã.ããã€ãã®æ ¢æ§çŸæ£ã®æçç©è³ªãã... ãã£ãšèŠã